BioAffinity Technologies

FromJulie Anne Overton ([email protected])
Subject (108)bioAffinity Technologies Reports 1500% Year over Year Growth in Sales from Texas Beta Launch of CyPath® Lung
Preheader (149)͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­
Typography
Arial
Colors
Text Analysis
Body Words3327
Subject Words17
Body Emojis16
Subject Emojis1
Media Analysis
Text Links16
Image Links3
Total Links19
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px2758 px
X-Spam Score0.0
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

bioAffinity Technologies Reports 1500% Year over Year Growth in Sales from Texas Beta Launch of CyPath® Lung

͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­
bioAffinity Technologies Reports 1500% Year over Year Growth in Sales from Texas Beta Launch of CyPath® Lung